- Home
- NAMM vs DXR Comparison
NAMM vs DXR Comparison
Compare NAMM & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAMM | DXR |
|---|---|---|
| Founded | 2024 | 1970 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.0M | 59.0M |
| IPO Year | 2024 | 1995 |
Fundamental Metrics
Financial Performance| Metric | NAMM | DXR |
|---|---|---|
| Price | $1.09 | $10.41 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | ★ 1.5M | 23.1K |
| Earning Date | 10-01-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,446,345.00 |
| Revenue This Year | $38.63 | $44,489.33 |
| Revenue Next Year | $53.54 | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.91 | $8.56 |
| 52 Week High | $7.42 | $14.76 |
Technical Indicators
Market Signals| Indicator | NAMM | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 41.52 | 43.68 |
| Support Level | $0.93 | $10.28 |
| Resistance Level | $1.52 | $10.99 |
| Average True Range (ATR) | 0.12 | 0.63 |
| MACD | -0.00 | -0.11 |
| Stochastic Oscillator | 23.32 | 19.29 |
Price Performance
Historical ComparisonAbout NAMM Namib Minerals Ordinary Shares
Namib Minerals is a Pan-African multi-asset mining platform for precious and critical metals, particularly gold. The company is an established gold producer with an attractive portfolio of three gold mines in Zimbabwe, Africa. Its gold mines include How Mine, Mazowe Mine, and Redwing Mine. Its segments include the How Mine, the Mazowe Mine, and the Redwing Mine, and Others.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.